...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >PRODUCTION OF REACTIVE OXYGEN SPECIES, ITS EFFECT, DRUGS AND PLANT EXTRACT USED AS AN ANTIOXIDANT, CHELATOR ON THALASSEMIC PATIENT: A REVIEW
【24h】

PRODUCTION OF REACTIVE OXYGEN SPECIES, ITS EFFECT, DRUGS AND PLANT EXTRACT USED AS AN ANTIOXIDANT, CHELATOR ON THALASSEMIC PATIENT: A REVIEW

机译:活性氧物种的产生,其作用,药物和植物提取物用作抗氧剂,螯合剂对地中海贫血患者的作用:综述

获取原文
   

获取外文期刊封面封底 >>

       

摘要

β- Thalassemia is an inherited genetic disorder which is caused by different kinds of mutations in the HBB gene in chromosome 11. Due to several types of mutation in β- gene, globin chains cannot synthesise completely and free α-globin is highly unstable and readily precipitates bound heme and iron. In β- thalassemia these precipitated iron, repeated blood transfusion and increased gastrointestinal iron absorption lead to iron overload in the body. The increased free iron in blood is responsible for the formation of Reactive Oxygen Species (ROS). If the production of ROS exceeds the capacity of enzymatic and non-enzymatic antioxidants systems to scavenge these species or if these protective systems are compromised, then oxidative stress occurs. This review summarizes the production of ROS, its effect and different drug and plant extract used as an antioxidant as well as chelating agent in thalassemic patient
机译:β-地中海贫血是一种遗传性遗传疾病,由11号染色体HBB基因的各种突变引起。由于β-基因的几种突变,珠蛋白链无法完全合成,游离的α-珠蛋白高度不稳定且容易沉淀结合的血红素和铁。在β地中海贫血中,这些沉淀的铁,反复的输血和胃肠道铁吸收的增加导致体内铁超负荷。血液中游离铁的增加是导致活性氧(ROS)形成的原因。如果ROS的产生超过酶促和非酶促抗氧化剂体系清除这些物质的能力,或者如果这些保护体系受到损害,则会发生氧化应激。这篇综述总结了ROS的产生,其作用以及在地中海贫血患者中用作抗氧化剂和螯合剂的不同药物和植物提取物

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号